Apogee Therapeutics, Inc.
APGEDelisted Sep 3, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001974640
Apogee Therapeutics, Inc. was delisted on Sep 3, 2026; its insiders filed their last Form 4 on Sep 3, 2026; 288 institutions reported holding it in 13F filings for Q2 2026, worth $8.93B in total; Soros Fund Management was the only superinvestor holding it.
Q2 2025 vs. Q1 2025
How the institutions holding Apogee Therapeutics, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 169 | 2 | 183 | +16 |
| Shares | 61.5M | 5.97K | 57.8M | −3.64M (−5.9%) |
| Value | $2.30B | $223.0K | $2.51B | +$210.4M (+9.1%) |
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (38)
Institutions that held Apogee Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
Sold out (22)
Institutions that held Apogee Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Ra Capital Management, L.P. | 1,569,491 | $58.6M |
| Voloridge Investment Management, LLC | 167,991 | $6.28M |
| Dark Forest Capital Management LP | 29,871 | $1.12M |
| Twinbeech Capital LP | 24,298 | $907.8K |
| Corebridge Financial, Inc. | 18,563 | $693.5K |
| Squarepoint Ops LLC | 16,232 | $606.4K |
| Soleus Capital Management, L.P. | 16,000 | $597.8K |
| Jain Global LLC | 11,586 | $432.9K |
| CIBC World Markets Corp | 8,408 | $314.1K |
| Engineers Gate Manager LP | 5,988 | $223.7K |
| Wexford Capital LP | 2,879 | $107.6K |
| Point72 (DIFC) Ltd | 1,583 | $59.1K |
| Aster Capital Management (DIFC) Ltd | 1,050 | $33.0K |
| BI Asset Management Fondsmaeglerselskab A/S | 681 | $25.0K |
| Coldstream Capital Management Inc | 54 | $2.02K |
| Amundi | 35 | $1.23K |
| Sierra Ocean, LLC | 25 | $934 |
| Stephens Consulting, LLC | 10 | $374 |
| South State Corp. | 5 | $187 |
| Quantbot Technologies LP | 5 | $187 |
| WealthTrak Capital Management LLC | 5 | $187 |
| True Wealth Design, LLC | 1 | $38 |
Not filed for Q2 2025 yet (2)
Institutions that held Apogee Therapeutics, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Glenmede Trust Co NA | 5,915 | $221.0K |
| Lindbrook Capital, LLC | 54 | $2.02K |